Processa Pharmaceuticals Inc (PCSA) Stock Price, Quote & News

Company Profile

Processa Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops cancer therapy drugs to improve the safety and efficacy of cancer treatment in the United States. The company's drugs are modifications of existing FDA-approved oncology drugs, resulting in an alteration of the metabolism and/or distribution of drugs while maintaining the existing mechanisms for killing cancer cells. Its oncology pipeline includes NGC-Cap (PCS6422), a combination of PCS6422 and capecitabine, whi...

Industry: Biotechnology

Sector: Healthcare

Phone: 772 453 2899

Fax: 443 288 4420

Website: www.processapharmaceuticals.com

Address:

601 21st Street, Suite 300, Vero Beach, United States

BillionerOfKing May. 1 at 1:25 AM

$PCSA Current Stock Price: $2.68

0 · Reply

Chilliboy Apr. 29 at 2:10 PM

$PCSA at this point we are gonna get ww3 befor some news

1 · Reply

TheDrunkTrader69 Apr. 28 at 9:13 PM

$PCSA I have been here way to long lol, but know it can launch 10x in a heart beat, watch this closely

0 · Reply

SDBiotechInvestor Apr. 28 at 5:14 PM

$PCSA - final step in Dreyfus near term milestones: US launch. World cup about 5 weeks away. May will be interesting.

1 · Reply

OfficialStocktwitsUser Apr. 28 at 3:12 PM

$PCSA RSI: 46.41, MACD: 0.0753 Vol: 0.17, MA20: 2.89, MA50: 2.66 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

Mongomoney Apr. 27 at 6:55 PM

$PCSA what’s going on ? Very low volume today ? I’m still very optimistic…

1 · Reply

SDBiotechInvestor Apr. 25 at 2:55 PM

$PCSA - Next week it is

0 · Reply

TheDrunkTrader69 Apr. 24 at 4:19 PM

$PCSA waiting news then 3 to 30 launch

1 · Reply

Tetoooo Apr. 24 at 8:59 AM

$PCSA something fishy is happening here

0 · Reply

SuperGreenToday Apr. 24 at 12:57 AM

$PCSA

0 · Reply

Processa Pharmaceuticals to Attend 44th Annual J.P. Morgan Healthcare Conference

Jan 5, 2026, 9:15 AM EST - 4 months ago

Processa Pharmaceuticals Completes Enrollment of 20th Patient for Formal Interim Analysis in Phase 2 NGC-Cap Breast Cancer Study

Dec 17, 2025, 1:10 PM EST - 4 months ago

Why Is Small-Cap Processa Pharmaceuticals Stock Rallying After Breast Cancer Trial Data?

Dec 17, 2025, 8:00 AM EST - 4 months ago

Processa Pharmaceuticals Provides Clinical Update on Phase 2 Study in Metastatic Breast Cancer

Nov 5, 2025, 9:15 AM EST - 6 months ago

Processa Pharmaceuticals Announces Poster Presentation of Adaptive Phase 2/3 PCS499 Study in FSGS at ASN Kidney Week 2025

Aug 7, 2025, 8:30 AM EDT - 9 months ago

Processa Pharmaceuticals Secures Strategic Investment and Evaluates Corporate Crypto Treasury Strategies

Jul 9, 2025, 4:15 PM EDT - 10 months ago

Processa Pharmaceuticals Transcript: Status Update

Jul 1, 2025, 9:00 AM EDT - 10 months ago

Processa Pharmaceuticals Provides Portfolio and Business Update

Jun 17, 2025, 12:26 PM EDT - 11 months ago

Processa Pharmaceuticals Announces Pricing of $7 Million Public Offering

Jun 17, 2025, 9:00 AM EDT - 11 months ago

Processa Pharmaceuticals Signs Binding Term Sheet Granting Intact Therapeutics Exclusive Option to License Phase 2 Gastroparesis Drug Candidate

Jun 13, 2025, 8:00 AM EDT - 11 months ago

Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025

May 30, 2025, 9:00 AM EDT - 11 months ago

Processa Pharmaceuticals Announces Presentation and Publication of Three Abstracts at 2025 ASCO Annual Meeting

Apr 15, 2025, 8:00 AM EDT - 1 year ago

Processa Pharmaceuticals' Dr. David Young to Present at World Orphan Drug Congress USA 2025

Mar 18, 2025, 8:30 AM EDT - 1 year ago

Processa Pharmaceuticals to Present at the MedInvest Biotech and Pharma Investor Conference

Feb 7, 2025, 8:00 AM EST - 1 year ago

Processa Pharmaceuticals to Present at the 2025 BIO CEO & Investor Conference

Jan 30, 2025, 5:17 PM EST - 1 year ago

Processa Pharmaceuticals Announces Closing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Jan 27, 2025, 8:30 PM EST - 1 year ago

Processa Pharmaceuticals Announces Pricing of $5 Million Public Offering Priced At-The-Market Under Nasdaq Rules

Oct 2, 2024, 4:05 PM EDT - 1 year ago

Processa Pharmaceuticals Announces First Patient Dosed in Phase 2 Clinical Trial of NGC-Cap in Metastatic Breast Cancer

Sep 9, 2024, 7:00 AM EDT - 1 year ago

Processa Pharmaceuticals Transcript: H.C. Wainwright 26th Annual Global Investment Conference 2024

Sep 3, 2024, 8:00 AM EDT - 1 year ago

Processa Pharmaceuticals to Participate in Investor and Industry Conferences During September

Jun 11, 2024, 8:20 AM EDT - 2 years ago

Processa Pharmaceuticals Announces Positive Efficacy Results from Preliminary Evaluation of Phase 1b Dose-escalating Trial with NGC-Cap in Gastrointestinal Cancer

May 6, 2024, 8:00 AM EDT - 2 years ago

Processa Pharmaceuticals to Participate in the EF Hutton Annual Global Conference

Apr 30, 2024, 8:00 AM EDT - 2 years ago

Processa Pharmaceuticals Names Dr. Steven Cha Senior Vice President of Clinical Research

Mar 25, 2024, 8:15 AM EDT - 2 years ago

Processa Pharmaceuticals to Present Data at the American Association for Cancer Research Annual Meeting

Feb 21, 2024, 8:15 AM EST - 2 years ago

Processa Pharmaceuticals to Present at the 2024 BIO CEO & Investor Conference

Feb 20, 2024, 1:30 PM EST - 2 years ago

Processa Pharmaceuticals Transcript: The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference

Feb 14, 2024, 1:00 PM EST - 2 years ago

Processa Pharmaceuticals to Present at The Winter Wrap-Up MicroCap Rodeo Winter 2024 Virtual Conference

Feb 6, 2024, 8:30 AM EST - 2 years ago

Processa Pharmaceuticals Regains Compliance with Nasdaq Minimum Bid Price Rule

Feb 1, 2024, 4:22 PM EST - 2 years ago

Processa Pharmaceuticals Announces Closing of $7.0 Million Public Offering

Jan 26, 2024, 9:04 AM EST - 2 years ago

Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering

Jan 25, 2024, 11:29 AM EST - 2 years ago

What made Processa Pharmaceuticals stock nearly triple on Thursday?

Jan 25, 2024, 8:30 AM EST - 2 years ago

Processa Pharmaceuticals Announces Successful Completion of Phase 1b Safety Evaluation of NGC-Cap in Patients with Advanced Cancer Resulting in Recommended Phase 2 Doses

Jan 19, 2024, 7:45 AM EST - 2 years ago

Processa Pharmaceuticals Announces Expansion of NGC-Cap Program into Advanced or Metastatic Breast Cancer

Jan 18, 2024, 7:45 AM EST - 2 years ago

Processa Pharmaceuticals to Effect a 1-for-20 Reverse Stock Split

Jan 2, 2024, 5:06 PM EST - 2 years ago

Processa Pharmaceuticals to Present at the Biotech Showcase 2024

Dec 19, 2023, 9:00 AM EST - 2 years ago

Processa Pharmaceuticals Provides Interim Analysis from Ongoing Phase 1b Trial of Next Generation Capecitabine Showing Improved Safety Over Capecitabine

Dec 13, 2023, 9:00 AM EST - 2 years ago

Processa Pharmaceuticals Announces Successful Phase 2 Meeting with FDA for Next Generation Capecitabine

Nov 30, 2023, 8:15 AM EST - 2 years ago

Processa Pharmaceuticals to Present at the MedInvest Oncology Investor Conference

Nov 29, 2023, 8:15 AM EST - 2 years ago

Processa Pharmaceuticals Issues Letter to Shareholders Highlighting Corporate Strategy, Drug Pipeline, and Outlook

Nov 13, 2023, 1:40 PM EST - 2 years ago

Processa Pharmaceuticals, Inc. Mourns the Sudden Passing of Board Member Virgil Thompson

Nov 9, 2023, 8:15 AM EST - 2 years ago

Processa Pharmaceuticals to Present at the 20th Orphan Drugs and Rare Diseases Global Congress 2023 Americas

Nov 1, 2023, 8:15 AM EDT - 2 years ago

Processa Pharmaceuticals Announces Formation of Oncology Advisory Board with Renowned Key Opinion Leaders

Oct 13, 2023, 1:08 PM EDT - 2 years ago

Processa Pharmaceuticals to Present at the ThinkEquity Conference

Sep 6, 2023, 8:15 AM EDT - 2 years ago

Processa Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

Aug 17, 2023, 8:05 AM EDT - 2 years ago

Processa Pharmaceuticals Provides Data Update Supporting a Potential Personalized Treatment Approach for Improved Cancer Care

Aug 10, 2023, 4:15 PM EDT - 2 years ago

Processa Pharmaceuticals to Present at the Sidoti & Co. Micro Cap Virtual Conference

Aug 8, 2023, 8:15 AM EDT - 2 years ago

Processa Pharmaceuticals Appoints Life Sciences Industry Veteran George Ng as Chief Executive Officer

Jun 14, 2023, 4:15 PM EDT - 3 years ago

Next Generation Chemotherapy: Improved Treatment for More Patients

May 22, 2023, 8:05 AM EDT - 3 years ago

Processa Pharmaceuticals to Participate in a Panel on Interaction with the FDA at the World Orphan Drug Congress

May 18, 2023, 8:00 AM EDT - 3 years ago

Processa Pharmaceuticals to Conduct Next Generation Chemotherapy-Capecitabine Phase 2 Trial Based on FDA Guidance and Project Optimus Oncology Initiative

Apr 28, 2023, 8:15 AM EDT - 3 years ago

Processa Pharmaceuticals to Present PCS12852 Gastroparesis Results at the Digestive Disease Week 2023 Annual Meeting

Mar 30, 2023, 4:01 PM EDT - 3 years ago

Processa Pharmaceuticals Provides Corporate Update and Announces Year End 2022 Financial Results

Mar 30, 2023, 2:30 AM EDT - 3 years ago

Processa Pharmaceuticals Earnings Call Transcript: Q4 2022

Mar 23, 2023, 8:30 AM EDT - 3 years ago

Processa Pharmaceuticals to Host Conference Call to Discuss 2022 Year End Results and Provide Drug Development Update on March 30, 2023 at 4:30 p.m. EST

Nov 8, 2022, 2:00 AM EST - 3 years ago

Processa Pharmaceuticals Earnings Call Transcript: Q3 2022

BillionerOfKing May. 1 at 1:25 AM

$PCSA Current Stock Price: $2.68

0 · Reply

Chilliboy Apr. 29 at 2:10 PM

$PCSA at this point we are gonna get ww3 befor some news

1 · Reply

TheDrunkTrader69 Apr. 28 at 9:13 PM

$PCSA I have been here way to long lol, but know it can launch 10x in a heart beat, watch this closely

0 · Reply

SDBiotechInvestor Apr. 28 at 5:14 PM

$PCSA - final step in Dreyfus near term milestones: US launch. World cup about 5 weeks away. May will be interesting.

1 · Reply

OfficialStocktwitsUser Apr. 28 at 3:12 PM

0 · Reply

Mongomoney Apr. 27 at 6:55 PM

$PCSA what’s going on ? Very low volume today ? I’m still very optimistic…

1 · Reply

SDBiotechInvestor Apr. 25 at 2:55 PM

$PCSA - Next week it is

0 · Reply

TheDrunkTrader69 Apr. 24 at 4:19 PM

$PCSA waiting news then 3 to 30 launch

1 · Reply

Tetoooo Apr. 24 at 8:59 AM

$PCSA something fishy is happening here

0 · Reply

SuperGreenToday Apr. 24 at 12:57 AM

$PCSA

0 · Reply

SDBiotechInvestor Apr. 23 at 8:34 PM

$PCSA - CHZ breaking out on heavy volume as we speak. Crypto is just like biotech; people know things in advance.

1 · Reply

Kinderla Apr. 23 at 6:56 PM

$PCSA Aren’t we supposed to have a data release soon? I know we are excited about the Dreyfus crypto angle but we are still a biotech company. It seems like some good data stacked with the crypto pivot would have a lot of value.

3 · Reply

skyrockets_Inc Apr. 23 at 5:32 PM

$PCSA To those who keep repeating they are tapping into the ATM, very possible. However, as of Dec they had already used 3M of the 5.2M total allowed, so the most they could be tapping into right now would be ~2M or approx. 700k shares at $3/share. 2.6m shares OS as of Dec 2025, worst case now would be ~3.3m OS. FWIW

1 · Reply

SDBiotechInvestor Apr. 23 at 4:20 PM

$PCSA CHZ coin trying to breakout on the daily chart. I think we know what's going on here :)

1 · Reply

ony2k Apr. 22 at 10:20 PM

$PCSA Socios IPO in the news? Nada. What the likehood reverse merger is in the works and the deal closes before the World Cup opener June 11.

2 · Reply

SDBiotechInvestor Apr. 22 at 7:17 PM

$PCSA - We are about to be a part of something very special :)

1 · Reply

SDBiotechInvestor Apr. 22 at 4:39 PM

$PCSA - So guys. I probably can post this so everyone can know what is gonna happen. The Dreyfus theory was 100% right. We are going to be transitioning to DTA soon and help SOCIOS go public in the USA. Go to the 12:30 mark and listen. Dreyfus is specifically talking about $PCSA. I expect news before World Cup. Should be quite a substantial move in the stock. https://www.youtube.com/watch?v=m8TQPGQ7ykU&t=677s

2 · Reply

SDBiotechInvestor Apr. 22 at 3:18 PM

$PCSA - up to ~ 45k shares. Let's just say I "found out" with 100% certainty what is going to happen here in the very near future.

4 · Reply

smartmoney43 Apr. 22 at 2:32 PM

$PCSA looks interesting

0 · Reply

Rampageusa Apr. 22 at 2:06 PM

$PCSA good move,,need 5.5/7.5…++

0 · Reply

Stock_Catcher Apr. 21 at 1:08 PM

$PCSA Thin

1 · Reply

SDBiotechInvestor Apr. 21 at 1:05 PM

$PCSA Dreyfus's CHZ crushing it this past month. Lots of momentum on heels of SEC approval (company plans to invest 50-100 million in USA this year) and other project developments. I suspect he will make his move here soon.

1 · Reply

Market Cap	7.05M
Revenue (ttm)	0.00
Net Income (ttm)	-13.56M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	13,000
Avg Vol	55,036
Day's Range	N/A - N/A
Shares Out	2.66M
Stochastic %K	15%
Beta	0.89
Analysts	Sell
Price Target	$25.00